North Central London
Joint Formulary
8 Malignant disease and immunosuppression

The formulary for systemic anti-cancer treatments should be viewed alongside the 'National Cancer Drugs Fund list'

08-01-05 Mitotane


Approved for metastatic adrenocortical carcinoma (JFC February 2018)

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • This drug for the treatment of malignant disease must be prescribed on chemocare (RFL electronic chemotherapy prescribing system).  Additionally for in-patients this drug must be prescribed on an in-patient prescription chart (paper or electronic)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary

GP - Red View adult BNF  View SPC online  View childrens BNF